% Expired Patents = 75.0

Forward Citations = 19

Loading Chart...

1 inventor (with patents filed for the assignee):

Andrew Xian Chen (4 out of 37 patents)

4 patents: Sort by Forward Citations

1. 8222268 - Methods for reducing vein irritation (2012-07-17),

2. 8026250 - Compositions for delivering highly water soluble drugs (2011-09-27),

3. 7968122 - Anti-viral pharmaceutical compositions (2011-06-28),

4. 7871632 - Compositions for delivering highly water soluble drugs (2011-01-18),

Adventrx Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of proprietary product candidates for the treatment of cancer and infectious diseases. The company's lead product candidate is Ethyol, a cytoprotective agent used in cancer therapy to reduce the incidence of chemotherapy-induced side effects. Adventrx is dedicated to improving patient outcomes and quality of life through innovative drug development.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#1,006 in San Diego, CA

#14,041 in California

#60,597 in US

San Diego, CA, United States of America

Adventrx Pharmaceuticals, Inc.

Forward Citations = 19

1 inventor:

Andrew Xian Chen (4 out of 37 patents)

Please report any incorrect information to [email protected]